JAM
Jupiter Asset Management Portfolio holdings
AUM
$12B
1-Year Return
24.68%
This Quarter Return
+7.79%
1 Year Return
+24.68%
3 Year Return
+84.22%
5 Year Return
+156.46%
10 Year Return
+400.84%
AUM
$7.24B
AUM Growth
+$400M
(+5.9%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
24.3%
Holding
528
New
82
Increased
131
Reduced
126
Closed
121
Top Buys
| 1 |
Western Union
WU
|
+$74M |
| 2 |
Netflix
NFLX
|
+$68M |
| 3 |
McKesson
MCK
|
+$39.1M |
| 4 |
Xcel Energy
XEL
|
+$38.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$37.7M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$47.7M |
| 2 |
Edwards Lifesciences
EW
|
+$42.3M |
| 3 |
Vistra
VST
|
+$40.5M |
| 4 |
Royal Gold
RGLD
|
+$39M |
| 5 |
Merck
MRK
|
+$38.3M |
Sector Composition
| 1 | Technology | 29.27% |
| 2 | Healthcare | 12.54% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Usana Health Sciences
USNA
$545M
| $1.15M | 0.02% |
18,244
+5,935
| +48% | +$373K |
|
302
Verizon
VZ
$182B
| $1.14M | 0.02% |
29,438
-661,019
| -96% | -$25.7M |
|
303
RenaissanceRe
RNR
$11.2B
| $1.12M | 0.02% |
5,607
-34,990
| -86% | -$7.01M |
|
304
Opko Health
OPK
$1.14B
| $1.11M | 0.02% |
765,198
| – | – |
|
305
Nexstar Media Group
NXST
$5.98B
| $1.1M | 0.02% |
6,376
| – | – |
|
306
S&T Bancorp
STBA
$1.49B
| $1.09M | 0.02% |
34,711
-6,143
| -15% | -$193K |
|
307
V2X
VVX
$1.73B
| $1.05M | 0.01% |
26,562
+9,568
| +56% | +$380K |
|
308
Stride
LRN
$7B
| $1.03M | 0.01% |
26,325
-955
| -4% | -$37.5K |
|
309
Rithm Capital
RITM
$6.62B
| $1.02M | 0.01% |
127,758
-42,347
| -25% | -$338K |
|
310
Iovance Biotherapeutics
IOVA
$847M
| $1M | 0.01% |
164,360
+13,400
| +9% | +$81.7K |
|
311
Jackson Financial
JXN
$6.73B
| $996K | 0.01% |
26,636
-6,546
| -20% | -$245K |
|
|
TVRD
312
Tvardi Therapeutics, Inc. Common Stock
TVRD
$300M
| $991K | 0.01% |
5,621
| – | – |
|
313
Cathay General Bancorp
CATY
$3.42B
| $961K | 0.01% |
27,851
| – | – |
|
314
Essent Group
ESNT
$6.29B
| $938K | 0.01% |
23,433
-57,635
| -71% | -$2.31M |
|
315
Bandwidth Inc
BAND
$451M
| $934K | 0.01% |
+61,469
| New | +$934K |
|
316
LPL Financial
LPLA
$27.2B
| $918K | 0.01% |
4,535
-9,029
| -67% | -$1.83M |
|
317
Exact Sciences
EXAS
$10.3B
| $901K | 0.01% |
13,282
-12,920
| -49% | -$876K |
|
318
Five Star Bancorp
FSBC
$701M
| $899K | 0.01% |
42,201
-66,798
| -61% | -$1.42M |
|
319
Avanos Medical
AVNS
$558M
| $883K | 0.01% |
29,703
+4,217
| +17% | +$125K |
|
320
Gartner
IT
$17.6B
| $869K | 0.01% |
+2,670
| New | +$869K |
|
321
Haemonetics
HAE
$2.58B
| $856K | 0.01% |
10,350
+1,460
| +16% | +$121K |
|
322
Deluxe
DLX
$853M
| $835K | 0.01% |
52,235
+39,923
| +324% | +$638K |
|
323
Sea Limited
SE
$114B
| $822K | 0.01% |
+9,500
| New | +$822K |
|
|
324
Merck
MRK
$209B
| $775K | 0.01% |
7,291
-359,818
| -98% | -$38.3M |
|
325
Arcus Biosciences
RCUS
$1.24B
| $770K | 0.01% |
+42,234
| New | +$770K |
|